Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Dr. Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Staff Neonatologist and Developmental Pediatrician at University of Toronto | Canada

Dr. Kamini Raghuram is a clinician-scientist specializing in developmental and behavioral pediatrics, neonatal-perinatal medicine, and clinical epidemiology. With a strong foundation in pediatrics, she has combined clinical expertise with cutting-edge research to advance outcomes in high-risk and preterm infants. Her work bridges clinical practice, epidemiology, and innovative technological tools such as automated video-based analysis for motor impairment. Dr. Raghuram has been a principal and co-investigator on numerous funded projects and has published extensively in leading pediatric and neonatal journals. She is widely recognized for her dedication to improving long-term neurodevelopmental outcomes in vulnerable infant populations.

Publication Profile 

Orcid

Education 

Dr. Kamini Raghuram completed her Doctor of Medicine (MD) at the University of Toronto, followed by FRCPC training in General Pediatrics, Neonatal and Perinatal Medicine, and Developmental and Behavioral Pediatrics at the same institution. She earned a Master of Science in Clinical Epidemiology and Health Care Research from the Institute of Health Policy, Management, and Evaluation, University of Toronto, where her thesis focused on video-based motor impairment analysis in preterm infants. Earlier, she obtained a Bachelor of Applied Science in Chemical and Biological Engineering from the University of British Columbia, graduating as class valedictorian and recognized for outstanding research proficiency.

Experience 

Dr. Kamini Raghuram has held extensive clinical and academic positions across pediatrics, neonatology, and developmental medicine. She has served as a clinician-investigator, integrating patient care with translational research to develop evidence-based approaches for preterm infants. Her work includes leading clinical trials, advancing quality improvement initiatives, and applying machine learning and automated video analysis for early detection of motor and neurodevelopmental impairments. With expertise spanning neonatal intensive care, developmental follow-up, and health outcomes research, she has collaborated nationally and internationally to improve clinical pathways for high-risk infants. Her experience reflects a unique combination of bedside practice and pioneering research in pediatrics.

Awards and Honors 

Dr. Kamini Raghuram has received numerous awards and funding recognitions for her research and clinical excellence. These include CIHR grants exceeding $2 million, innovation fund competitions, and recognition for her work on neonatal outcomes. She has won presentation and research awards at the University of Toronto, The Hospital for Sick Children, and international conferences. Honors such as the Excellence in Academic Coaching Award, Quality Improvement Award, Canada Graduate Scholarship, and early-career fellowships highlight her leadership and academic impact. Earlier, as an engineering student, she received the Lefevre Gold Medal and delivered the valedictorian address at the University of British Columbia.

Research Focus 

Dr. Kamini Raghuram research focuses on improving neurodevelopmental and health outcomes in preterm and high-risk infants through early detection, intervention, and long-term follow-up strategies. She applies advanced tools, including automated video analysis, MRI biomarkers, and large-scale database studies, to identify predictors of motor and cognitive impairment. Her work integrates clinical epidemiology with neonatal and developmental pediatrics, emphasizing translational approaches from bench to bedside. She is also involved in clinical trials addressing interventions such as coadministration therapies and surgical decision-making in fetal medicine. Her ultimate goal is to enhance early diagnosis, optimize interventions, and improve quality of life for vulnerable children.

Publication Top Notes

Caregiver Experiences, Healthcare Provider Perspectives and Child Outcomes with Virtual Care in a Neonatal Neurodevelopmental Follow-Up Clinic: A Mixed-Methods Study

Automated Movement Analysis to Predict Cerebral Palsy in Very Preterm Infants: An Ambispective Cohort Study

Conclusion

Dr. Kamini Raghuram is a highly deserving candidate for the Best Researcher Award. Her career reflects a rare combination of clinical excellence, research innovation, and dedication to improving outcomes for preterm infants. With substantial grant funding, groundbreaking studies in automated movement analysis, and leadership in advancing neonatal care, she exemplifies the qualities of a leading researcher. While opportunities exist to expand her global influence and further scale her innovations, her proven track record of impactful, patient-centered research makes her an outstanding nominee for this prestigious recognition.

Ratree Sawangjit | Pharmacovigilance | Best Researcher Award

Ratree Sawangjit | Pharmacovigilance | Best Researcher Award

Assist Prof Dr Ratree Sawangjit, Mahasarakham University, Thailand

Assist. Prof. Dr. Ratree Sawangjit 🌿, a distinguished educator and researcher, has been a faculty member at Mahasarakham University’s Faculty of Pharmacy since 2006. She earned her Ph.D. in Biopharmaceutical Sciences 🧪 from Mahidol University. Her expertise spans clinical trials, herbal medicine, and evidence-based synthesis 📊. As Head of CTEBs Research Unit and IRB/EC, she leads impactful research projects. Dr. Sawangjit has held roles at Monash University 🌏 and contributed to WHO-GCTM initiatives. Recognized as an outstanding researcher 🏆, her work bridges clinical pharmacology, public health, and education, fostering innovative healthcare solutions.

Publication Profile

Google Scholar

Education

Assist. Prof. Dr. Ratree Sawangjit is a distinguished academic in pharmaceutical sciences 🎓💊. She earned her Ph.D. in Biopharmaceutical Sciences (International Program) from Mahidol University, Faculty of Pharmacy, Bangkok, Thailand (2008-2012) 🧪📚. Prior to this, she completed her Master’s in Pharmacy, specializing in Pharmaceutical Sciences (International Program), at Naresuan University, Thailand (2004-2006) 🏫🔬. Her journey in pharmacy began with a Bachelor of Pharmacy degree from Chiang Mai University, Thailand (1999-2004) 🌿📖. With her extensive education and expertise, she contributes significantly to the field of biopharmaceutical sciences through teaching and research 🌟📊.

Experience

Assist. Prof. Dr. Ratree Sawangjit is a dedicated faculty member at the Department of Clinical Pharmacy, Mahasarakham University (2006–present) 📚💊. She earned her Ph.D. in Biopharmaceutical Sciences from Mahidol University 🎓 (2012) and holds advanced degrees in Pharmacy from Naresuan and Chiang Mai Universities. Dr. Sawangjit mentors students in clinical pharmacology, integrating research and practice 🧪✨. As a Clinical Research Associate (2009–2020), she contributed to impactful public health policies 🌍💡. She also led health promotion projects and served as Assistant Dean for Student Affairs (2013–2015) 🎓🤝. Currently, she heads the IRB/EC, ensuring ethical compliance in research standards ✅📋.

Research Expertise

Assist. Prof. Dr. Ratree Sawangjit is an expert in clinical trials, specializing in the design, implementation, and analysis of studies with a focus on herbal and alternative medicines 🌿🧪. She excels in evidence-based synthesis, conducting systematic reviews, meta-analyses, and network meta-analyses 📚📊. Her expertise extends to clinical pharmacology, particularly in pain and inflammation management 💊🔥. Additionally, she is proficient in health economic evaluation, including cost-effectiveness analysis and healthcare resource utilization analysis 💰🏥. Dr. Sawangjit’s work combines cutting-edge research with practical applications, advancing both patient care and healthcare efficiency. 🌟

Awards and Honors

Assist. Prof. Dr. Ratree Sawangjit is an accomplished academic and researcher. She earned a Bachelor of Pharmacy with second-class honors from Chiang Mai University in 2004 🎓💊. Supported by the Thailand Research Fund, she completed her Master’s (2004–2006) and Ph.D. (2008–2012) programs 🧠📚. As a visiting research assistance scholar, she collaborated with Monash University’s School of Pharmacy in Malaysia (2015–2016) 🌏🔬. She was named Outstanding Researcher of the Faculty of Pharmacy at Mahasarakham University in 2019 and Outstanding Researcher of Mahasarakham University in 2021 🏆✨. Her journey reflects dedication to advancing pharmaceutical education and research. 🌟

Research Focus

Assist. Prof. Dr. Ratree Sawangjit’s research focuses on evidence-based healthcare, particularly through systematic reviews and meta-analyses. Her studies span diverse areas, including burn wound healing 🌱🔥, pharmacological treatments for dementia-related agitation 🧠💊, peripheral neuropathy 🌐🦶, and nonalcoholic fatty liver disease 🩺🫀. She has also investigated the cost-effectiveness of genetic testing in preventing drug-induced reactions 🧬💉 and assessed cannabis and cannabinoids for pain management 🌿🤕. Other key areas include treatments for eczema 🧴🛁 and musculoskeletal pain 🦴🩹. Dr. Sawangjit’s work significantly contributes to optimizing therapeutic interventions and advancing global health outcomes. 🌍📚

Publication Top Notes

The efficacy of aloe vera used for burn wound healing: a systematic review

Cost-effectiveness analysis of HLA-B* 5801 testing in preventing allopurinol-induced SJS/TEN in Thai population

Effectiveness of pharmacy‐based needle/syringe exchange programme for people who inject drugs: a systematic review and meta‐analysis

Pharmacological treatments for alleviating agitation in dementia: a systematic review and network meta‐analysis

Efficacy and safety of mecobalamin on peripheral neuropathy: a systematic review and meta-analysis of randomized controlled trials

Comparative efficacy of interventions on nonalcoholic fatty liver disease (NAFLD): A PRISMA-compliant systematic review and network meta-analysis

The effects of cannabis, cannabinoids, and their administration routes on pain control efficacy and safety: A systematic review and network meta-analysis